ArticleOncotarget2018

Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study.

Jacob A Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.